Week in Review: June 16–20

Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

JAVIER TRUEBA/MADRID SCIENTIFIC FILMSSeventeen skulls excavated from Spain’s Sima de los Huesos and thought to be around 430,000 years old are the oldest specimens with Neanderthal features uncovered to date. Researchers from Complutense University of Madrid reported on their analysis of these skulls in Science this week (June 19). The team found evidence suggesting that these ancient individuals were not fully Neanderthal, yet not quite Homo heidelbergensis, either.

“Until recently, most [scientists] supported [the idea] that Neanderthals emerged, at most, 250,000 years ago. The discovery at Sima demonstrates that there is a much deeper history of the Neanderthals than we previously thought, to at least 430,000 years ago,” said Jean-Jacques Hublin from the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, who was not involved in the work. “[These new specimens] are clearly not like the late Neanderthals, but ancestral forms of Neanderthals.”

FLICKR, JULIEN HARNEISThere are two antiviral drugs being tested to treat polio, and researchers battling the spread of the disease where vaccination is incomplete are banking on their success. One of the drugs, pocapavir, has shown promise in early clinical trials. But scientists face the lingering challenge of containing poliovirus excretion by immunocompromised persons who have been vaccinated.

“There can be no true eradication of polio with the continued presence of prolonged poliovirus excreters,” Mark McKinlay, head of the Polio Antivirals Initiative within The Task Force for Global Health, told The Scientist in an e-mail.

FLICKR, NATIONAL MUSEUM OF HEALTH AND MEDICINEThe Scientist continued its deep dive into the human microbiomes outside of the gastrointestinal tract this week, with a look at the microbial communities that inhabit the mouth and skin.

“Particularly for skin, we are only just now understanding who is there,” said Heidi Kong from the National Cancer Institute. “The next, much more complex part of this is what are they doing there and how are we ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide